Fairmount Healthcare Fund II L.P. 4

Accession 0001104659-25-058580

CIK 0001590750other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:00 PM ET

Size

16.9 KB

Accession

0001104659-25-058580

Form 4

Period: 2025-06-09

Director10% Owner

Transactions

Exercise/Conversion
Common Stock
2025-06-09$7.80/sh+1,600$12,480→ 3,447,413 total(indirect: Fairmount Healthcare Fund II LP)
Exercise/Conversion
Common Stock
2025-06-10$12.31/sh+12,500$153,875→ 3,459,913 total(indirect: Fairmount Healthcare Fund II LP)
Exercise/Conversion
Stock Option (Right to Buy)
2025-06-10−12,500→ 0 total(indirect: By: Peter Harwin)
Exercise: $12.31From: 2023-06-08Exp: 2025-06-10→ Common Stock (12,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-06-09−1,600→ 0 total(indirect: By: Peter Harwin)
Exercise: $7.80Exp: 2025-06-10→ Common Stock (1,600 underlying)

Director10% Owner

Transactions

Exercise/Conversion
Common Stock
2025-06-09$7.80/sh+1,600$12,480→ 3,447,413 total(indirect: Fairmount Healthcare Fund II LP)
Exercise/Conversion
Stock Option (Right to Buy)
2025-06-10−12,500→ 0 total(indirect: By: Peter Harwin)
Exercise: $12.31From: 2023-06-08Exp: 2025-06-10→ Common Stock (12,500 underlying)
Exercise/Conversion
Common Stock
2025-06-10$12.31/sh+12,500$153,875→ 3,459,913 total(indirect: Fairmount Healthcare Fund II LP)
Exercise/Conversion
Stock Option (Right to Buy)
2025-06-09−1,600→ 0 total(indirect: By: Peter Harwin)
Exercise: $7.80Exp: 2025-06-10→ Common Stock (1,600 underlying)

Director10% Owner

Transactions

Exercise/Conversion
Common Stock
2025-06-09$7.80/sh+1,600$12,480→ 3,447,413 total(indirect: Fairmount Healthcare Fund II LP)
Exercise/Conversion
Common Stock
2025-06-10$12.31/sh+12,500$153,875→ 3,459,913 total(indirect: Fairmount Healthcare Fund II LP)
Exercise/Conversion
Stock Option (Right to Buy)
2025-06-10−12,500→ 0 total(indirect: By: Peter Harwin)
Exercise: $12.31From: 2023-06-08Exp: 2025-06-10→ Common Stock (12,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-06-09−1,600→ 0 total(indirect: By: Peter Harwin)
Exercise: $7.80Exp: 2025-06-10→ Common Stock (1,600 underlying)

Footnotes (3)

[F1]Fairmount Funds Management LLC ("Fairmount") and Fairmount Healthcare Fund II GP LLC ("Fairmount GP II") have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.
[F2]Beginning on October 27, 2020, the option vested monthly over a three-year period, subject to Peter Harwin's continued service to the Issuer. Mr. Harwin, a Managing Member of Fairmount and Fairmount GP II, served on the Issuer's Board of Directors through March 10, 2025.
[F3]Under Mr. Harwin's arrangement with Fairmount, Mr. Harwin held options received as director compensation from the Issuer for one or more investment vehicles managed by Fairmount (each, a "Fairmount Fund"). Mr. Harwin is obligated to turn over to Fairmount any net cash or stock received from such options for the benefit of such Fairmount Fund. Mr. Harwin therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein.

Documents

1 file

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

IncorporatedDE